No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective studyJournal of HepatologyVol. 73Issue 2PreviewLiver injury has been observed in patients with COVID-19, at an incidence ranging from 14–53%.1–3 We examined the liver injury patterns and implication of non-alcoholic fatty liver diseases (NAFLD) on clinical outcomes in Chinese patients with COVID-19. Full-Text PDF Reply to: ‘No evidence for an increased liver uptake of...